$1.67 Billion is the total value of ARMISTICE CAPITAL, LLC's 77 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 71.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPY | Sell | SPDR S&P 500 ETF TRput | $197,690,000 | +1.2% | 680,000 | -5.6% | 11.87% | -7.0% |
CERC | Buy | CERECOR INC | $81,727,000 | +14.7% | 17,500,400 | +6.6% | 4.91% | +5.5% |
CPB | Buy | CAMPBELL SOUP COcall | $73,260,000 | +77.2% | 2,000,000 | +96.1% | 4.40% | +62.9% |
CAKE | Buy | CHEESECAKE FACTORY INCcall | $58,894,000 | +105.7% | 1,100,000 | +111.5% | 3.54% | +89.0% |
HAIN | Buy | HAIN CELESTIAL GROUP INCcall | $54,240,000 | +127.5% | 2,000,000 | +150.0% | 3.26% | +109.1% |
SJM | Buy | SMUCKER J M CO | $52,947,000 | +52.0% | 516,000 | +59.3% | 3.18% | +39.8% |
INCY | New | INCYTE CORPcall | $48,356,000 | – | 700,000 | +100.0% | 2.90% | – |
CLVS | Buy | CLOVIS ONCOLOGY INC | $48,049,000 | +69.3% | 1,636,000 | +162.2% | 2.88% | +55.6% |
EPC | Sell | EDGEWELL PERS CARE CO | $46,230,000 | -16.1% | 1,000,000 | -8.4% | 2.78% | -22.9% |
MNKKQ | Sell | MALLINCKRODT PUB LTD CO | $45,137,000 | +0.8% | 1,540,000 | -35.8% | 2.71% | -7.4% |
AMAG | AMAG PHARMACEUTICALS INC | $41,600,000 | +2.6% | 2,080,000 | 0.0% | 2.50% | -5.7% | |
ENTA | Buy | ENANTA PHARMACEUTICALS INC | $38,970,000 | +171.2% | 456,000 | +267.7% | 2.34% | +149.4% |
PGNX | Buy | PROGENICS PHARMACEUTICALS IN | $38,611,000 | +89.4% | 6,158,000 | +142.8% | 2.32% | +74.2% |
UTHR | New | UNITED THERAPEUTICS CORP DEL | $37,341,000 | – | 292,000 | +100.0% | 2.24% | – |
HOG | Sell | HARLEY DAVIDSON INC | $37,327,000 | -11.3% | 824,000 | -17.6% | 2.24% | -18.4% |
HBI | Buy | HANESBRANDS INC | $36,860,000 | +30.8% | 2,000,000 | +56.2% | 2.21% | +20.2% |
KORS | Buy | MICHAEL KORS HLDGS LTD | $36,748,000 | +32.0% | 536,000 | +28.2% | 2.21% | +21.3% |
VYGR | Buy | VOYAGER THERAPEUTICS INC | $32,618,000 | +286.4% | 1,724,000 | +299.1% | 1.96% | +255.4% |
PLYA | Buy | PLAYA HOTELS & RESORTS NV | $32,280,000 | +1.8% | 3,352,000 | +14.2% | 1.94% | -6.4% |
CAR | New | AVIS BUDGET GROUP | $32,140,000 | – | 1,000,000 | +100.0% | 1.93% | – |
DFRG | Buy | DEL FRISCOS RESTAURANT GROUP | $31,175,000 | +147.4% | 3,756,000 | +275.6% | 1.87% | +127.3% |
ATRS | Sell | ANTARES PHARMA INC | $30,643,000 | -1.4% | 9,120,000 | -24.3% | 1.84% | -9.4% |
REGN | Sell | REGENERON PHARMACEUTICALS | $30,303,000 | -31.4% | 75,000 | -41.4% | 1.82% | -36.9% |
RL | New | RALPH LAUREN CORPcl a | $29,986,000 | – | 218,000 | +100.0% | 1.80% | – |
HAIN | New | HAIN CELESTIAL GROUP INC | $27,120,000 | – | 1,000,000 | +100.0% | 1.63% | – |
DESP | Sell | DESPEGAR COM CORP | $26,385,000 | -21.0% | 1,564,000 | -1.8% | 1.58% | -27.3% |
SGMS | Buy | SCIENTIFIC GAMES CORP | $22,860,000 | +26.4% | 900,000 | +144.6% | 1.37% | +16.2% |
VNDA | Sell | VANDA PHARMACEUTICALS INC | $20,655,000 | -51.2% | 900,000 | -59.5% | 1.24% | -55.2% |
QRTEA | Buy | QURATE RETAIL INC | $19,989,000 | +92.2% | 900,000 | +83.7% | 1.20% | +76.7% |
ASRT | New | ASSERTIO THERAPEUTICS INC | $17,640,000 | – | 3,000,000 | +100.0% | 1.06% | – |
PETS | New | PETMED EXPRESS INC | $17,561,000 | – | 532,000 | +100.0% | 1.05% | – |
MDGL | New | MADRIGAL PHARMACEUTICALS INC | $17,130,000 | – | 80,000 | +100.0% | 1.03% | – |
CLLS | New | CELLECTIS S Asponsored ads | $16,932,000 | – | 600,000 | +100.0% | 1.02% | – |
BBY | Buy | BEST BUY INC | $15,872,000 | +52.0% | 200,000 | +42.9% | 0.95% | +39.7% |
GPS | Sell | GAP INC DEL | $15,117,000 | -45.7% | 524,000 | -39.1% | 0.91% | -50.1% |
ZFGN | Sell | ZAFGEN INC | $13,607,000 | -11.3% | 1,164,000 | -22.4% | 0.82% | -18.5% |
SBBP | Buy | STRONGBRIDGE BIOPHARMA PLC | $12,853,000 | -0.7% | 2,650,000 | +22.8% | 0.77% | -8.7% |
BLUE | Sell | BLUEBIRD BIO INC | $12,848,000 | -54.5% | 88,000 | -51.1% | 0.77% | -58.2% |
ONCE | Buy | SPARK THERAPEUTICS INC | $12,437,000 | +0.2% | 228,000 | +52.0% | 0.75% | -7.9% |
RDUS | New | RADIUS HEALTH INC | $11,712,000 | – | 658,000 | +100.0% | 0.70% | – |
PRTK | Buy | PARATEK PHARMACEUTICALS INC | $11,640,000 | +0.8% | 1,200,000 | +6.0% | 0.70% | -7.3% |
ATEC | Buy | ALPHATEC HOLDINGS INC | $11,122,000 | +15.5% | 3,300,414 | +2.2% | 0.67% | +6.2% |
PERNIX THERAPEUTICS HLDGS INdbcv 4.250% 4/0 | $9,531,000 | +0.4% | 21,760,000 | 0.0% | 0.57% | -7.7% | ||
EAT | New | BRINKER INTL INC | $9,346,000 | – | 200,000 | +100.0% | 0.56% | – |
BDSI | Buy | BIODELIVERY SCIENCES INTL IN | $9,218,000 | +2482.1% | 3,292,000 | +2623.2% | 0.55% | +2304.3% |
FND | New | FLOOR & DECOR HLDGS INCcl a | $9,051,000 | – | 300,000 | +100.0% | 0.54% | – |
FB | Buy | FACEBOOK INCcl a | $8,223,000 | +135.1% | 50,000 | +177.8% | 0.49% | +116.7% |
LULU | New | LULULEMON ATHLETICA INC | $8,125,000 | – | 50,000 | +100.0% | 0.49% | – |
CVS | Sell | CVS HEALTH CORP | $7,872,000 | -75.5% | 100,000 | -80.0% | 0.47% | -77.5% |
SLDB | Sell | SOLID BIOSCIENCES INC | $7,738,000 | +20.7% | 164,000 | -8.9% | 0.46% | +10.7% |
TLRDQ | New | TAILORED BRANDS INC | $7,557,000 | – | 300,000 | +100.0% | 0.45% | – |
ACHN | Sell | ACHILLION PHARMACEUTICALS IN | $7,360,000 | -35.0% | 2,000,000 | -50.0% | 0.44% | -40.2% |
ALIM | ALIMERA SCIENCES INC | $6,797,000 | +0.2% | 6,936,000 | 0.0% | 0.41% | -7.9% | |
CPRX | Sell | CATALYST PHARMACEUTICALS INC | $6,320,000 | +19.2% | 1,672,000 | -1.6% | 0.38% | +9.5% |
VICL | VICAL INC | $5,974,000 | +19.1% | 4,360,500 | 0.0% | 0.36% | +9.8% | |
NVLNF | NOVELION THERAPEUTICS INC | $5,494,000 | -19.6% | 1,856,000 | 0.0% | 0.33% | -26.0% | |
FTCH | New | FARFETCH LTDord sh cl a | $5,446,000 | – | 200,000 | +100.0% | 0.33% | – |
MED | New | MEDIFAST INC | $5,317,000 | – | 24,000 | +100.0% | 0.32% | – |
TPX | Sell | TEMPUR SEALY INTL INC | $5,290,000 | -87.1% | 100,000 | -88.3% | 0.32% | -88.2% |
EYEG | EYEGATE PHARMACEUTICALS INC | $5,209,000 | -41.5% | 16,802,500 | 0.0% | 0.31% | -46.1% | |
APRN | New | BLUE APRON HLDGS INCcall | $5,160,000 | – | 3,000,000 | +100.0% | 0.31% | – |
CMRX | Buy | CHIMERIX INC | $5,057,000 | -15.5% | 1,300,000 | +3.3% | 0.30% | -22.3% |
NAKD | Buy | NAKED BRAND GROUP LIMITED | $4,917,000 | -51.5% | 1,828,000 | +14.2% | 0.30% | -55.4% |
PDLI | New | PDL BIOPHARMA INC | $4,734,000 | – | 1,800,000 | +100.0% | 0.28% | – |
JCPNQ | New | PENNEY J C INCcall | $3,818,000 | – | 2,300,000 | +100.0% | 0.23% | – |
T | New | AT&T INC | $3,358,000 | – | 100,000 | +100.0% | 0.20% | – |
ORMP | New | ORAMED PHARM INC | $3,039,000 | – | 624,000 | +100.0% | 0.18% | – |
IPCIF | New | INTELLIPHARMACEUTICS INTL IN | $2,305,000 | – | 860,000 | +100.0% | 0.14% | – |
PTIE | New | PAIN THERAPEUTICS INC | $2,186,000 | – | 2,164,000 | +100.0% | 0.13% | – |
DYNT | Buy | DYNATRONICS CORP | $1,570,000 | +0.8% | 551,046 | +1.8% | 0.09% | -7.8% |
APRI | New | APRICUS BIOSCIENCES INC | $1,426,000 | – | 4,600,000 | +100.0% | 0.09% | – |
ONTX | New | ONCONOVA THERAPEUTICS INC | $816,000 | – | 111,216 | +100.0% | 0.05% | – |
VXRT | Buy | VAXART INC | $428,000 | +82.1% | 150,000 | +93.3% | 0.03% | +73.3% |
RTTR | Buy | RITTER PHARMACEUTICALS INC | $339,000 | +841.7% | 182,000 | +1200.0% | 0.02% | +900.0% |
ROX | New | CASTLE BRANDS INC | $107,000 | – | 100,000 | +100.0% | 0.01% | – |
CTXR | New | CITIUS PHARMACEUTICALS INC | $100,000 | – | 58,431 | +100.0% | 0.01% | – |
TTNP | New | TITAN PHARMACEUTICALS INC DE | $46,000 | – | 220,000 | +100.0% | 0.00% | – |
ACHV | Exit | ACHIEVE LIFE SCIENCE INC | $0 | – | -62,000 | -100.0% | -0.02% | – |
ONTX | Exit | ONCONOVA THERAPEUTICS INC | $0 | – | -1,688,235 | -100.0% | -0.04% | – |
NOVN | Exit | NOVAN INC | $0 | – | -500,000 | -100.0% | -0.10% | – |
CATB | Exit | CATABASIS PHARMACEUTICALS IN | $0 | – | -2,000,000 | -100.0% | -0.12% | – |
STDY | Exit | STEADYMED LTD | $0 | – | -497,044 | -100.0% | -0.15% | – |
AMZN | Exit | AMAZON COM INC | $0 | – | -2,000 | -100.0% | -0.22% | – |
IPCI | Exit | INTELLIPHARMACEUTICS INTL IN | $0 | – | -8,600,000 | -100.0% | -0.25% | – |
ZOES | Exit | ZOES KITCHEN INC | $0 | – | -593,321 | -100.0% | -0.38% | – |
DSW | Exit | DSW INCcl a | $0 | – | -280,000 | -100.0% | -0.47% | – |
CRSP | Exit | CRISPR THERAPEUTICS AGnamen akt | $0 | – | -124,000 | -100.0% | -0.48% | – |
YELP | Exit | YELP INCcl a | $0 | – | -200,000 | -100.0% | -0.51% | – |
DEPO | Exit | DEPOMED INC | $0 | – | -1,177,900 | -100.0% | -0.51% | – |
PZZA | Exit | PAPA JOHNS INTL INC | $0 | – | -250,000 | -100.0% | -0.83% | – |
APRN | Exit | BLUE APRON HLDGS INCcl a | $0 | – | -4,000,000 | -100.0% | -0.88% | – |
ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -112,000 | -100.0% | -0.91% | – |
CELG | Exit | CELGENE CORP | $0 | – | -175,000 | -100.0% | -0.91% | – |
EPC | Exit | EDGEWELL PERS CARE COcall | $0 | – | -350,000 | -100.0% | -1.15% | – |
BGS | Exit | B & G FOODS INC NEW | $0 | – | -700,000 | -100.0% | -1.37% | – |
SMPL | Exit | SIMPLY GOOD FOODS CO | $0 | – | -1,460,000 | -100.0% | -1.38% | – |
TBPH | Exit | THERAVANCE BIOPHARMA INC | $0 | – | -1,180,000 | -100.0% | -1.75% | – |
FRPT | Exit | FRESHPET INCcall | $0 | – | -1,000,000 | -100.0% | -1.79% | – |
INCY | Exit | INCYTE CORP | $0 | – | -428,000 | -100.0% | -1.87% | – |
SEAS | Exit | SEAWORLD ENTMT INC | $0 | – | -1,576,000 | -100.0% | -2.25% | – |
PZZA | Exit | PAPA JOHNS INTL INCcall | $0 | – | -750,000 | -100.0% | -2.48% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
INCYTE CORP | 21 | Q3 2023 | 2.8% |
VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.